ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2025
A machine learning model to predict optimal antibiotic use in hospital medicine patients.
Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A consensus-weighted multi-agent ensemble feature selection framework for antibiotic susceptibility prediction in pediatric respiratory diseases.Frontiers in artificial intelligence · 2026Article
- Artificial intelligence in optimizing antimicrobial therapy for gastro-renal disorders.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Unnecessary and suboptimal antibiotic use causes adverse outcomes at both the level of individuals and health systems. Prospective audit and feedback, a core aspect of antibiotic stewardship program (ASP) efforts, reduces such use, but is inefficient in the absence of a pre-screening process. To address this, we used a machine learning approach to stratify antibiotic orders based on the likelihood of benefiting from ASP review, and to identify the factors most influential in the model's predictions. Design: Machine learning model developed using expert-labeled point-prevalence data. Setting: Single-center adult academic hospital. Participants: Hospitalized patients 18 years or older on internal medicine services between May 2021 and August 2022. Methods: Infectious disease experts assessed antibiotic orders for necessity and optimal use to create labels which were used as ground truth to train a machine learning model that uses automatically queried data from the electronic health record including vital signs, laboratory values, microbiological data, and medication administration records. Results: Our model achieved an area under the receiver operating characteristic curve of 0.89 for antibiotic necessity and 0.80 for optimal use. Model predictions were driven largely by markers of clinical instability, inflammation, and infection. Simpler clinical indices of infection had no predictive ability. Conclusions: We describe a model that predicts antibiotic necessity and optimal use using routinely available data that can be automatically aggregated from medical records. This makes it a promising option for early identification and intervention on orders most likely to benefit from ASP review.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.